Previous close | 3.5300 |
Open | 3.5300 |
Bid | 0.5500 |
Ask | 0.0000 |
Strike | 35.00 |
Expiry date | 2024-06-21 |
Day's range | 3.5300 - 3.5300 |
Contract range | N/A |
Volume | |
Open interest | 7 |
Shirley Kuhlmann, Executive Vice President and General Counsel of Collegium Pharmaceutical Inc (NASDAQ:COLL), sold 25,000 shares of the company on June 3, 2024.
On May 28, 2024, Colleen Tupper, Executive Vice President and Chief Financial Officer of Collegium Pharmaceutical Inc (NASDAQ:COLL), executed a sale of 19,710 shares of the company.
STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference being held in New York, NY from June 5-6, 2024. Details of the event are as follows:Fireside Chat Date and Time: Wednesday, June 5, 2024, at 9:30 a.m